Dermal Filler Market By Type (Hyaluronic acid (HA) , Calcium Hydroxylapatite (CaHA) , Poly L lactic Acid, Others) , By Gender (Male, Female) By Service Provider (Specialty and Dermatology Clinics, Hospitals, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Dermal Filler Market
The dermal filler market was valued at $6.3 billion in 2023, and is projected to reach $16.8 billion by 2033, growing at a CAGR of 10.3% from 2024 to 2033.
Dermal filler is a gel-like substance injected into the skin to restore its volume, smooth out its lines & wrinkles, and enhance the contours of the face. The injection of derma fillers is a non-surgical process which shows instant results and lasts for a few months to years, depending on the type of filler injected. Hyaluronic acid is the most common component of derma fillers used to hydrate and volumize the skin. Apart from synthetic fillers, there is a natural form of derma filler where fat from some other body part of a person is injected into the target body part. This process is known by the term — autologous fat grafting.
Rise in occurrence of ageing symptoms at an early stage is one of the major drivers of the dermal filler market. Moreover, increase in aesthetic awareness among individuals, particular females, due the influence of social media is boosting the demand for dermal fillers. In recent times, biostimulatory fillers are acquiring traction among individuals as they promote the production of natural collagen in the body. These fillers promote the natural regenerative process inside the body, hence are not comparable to chemical fillers.
However, the expenses of administering dermal filler injections are significantly high, which prevent a large population from availing the benefits. In addition, the post-procedure complications and side-effects are highly adverse in some individuals, hence making several individuals reluctant about administering such injections. Despite the chances of side effects, the cases of dermal fillers are increasing every year. The International Society of Aesthetic Plastic Surgery conducted a survey in 2023 to determine the statistics of surgical and non-surgical cosmetic procedures around the globe. According to this survey, named, International Survey on Aesthetic/Cosmetic Procedures, the cases of hyaluronic acid fillers upsurged by 29% in 2023, with maximum derma filler cases occurring in the U.S.
Segment Review
The global dermal filler market is segmented into type, gender, service provider, and region. On the basis of type, the market is divided into hyaluronic acid (HA), calcium hydroxylapatite (CaHA), poly L lactic acid, and others. By gender, it is bifurcated into male and female. Depending on service provider, it is classified into specialty & dermatology clinics, hospitals, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of type, the hyaluronic acid (HA) segment generated the largest revenue in the market in 2023.
By gender, the female segment dominated the dermal fillers market in 2023.
Depending on service provider, the hospitals segment was the largest stakeholder in 2023.
Region wise, North America was the highest revenue generator in 2023.
Competition Analysis
The major players operating in the global dermal filler market are Teoxane Laboratories, Cutera Inc, Elan aesthetics Inc, Bioxis pharmaceutical, AbbVie Laboratories, Sinclair Pharma, Sosum Global, Revance Therapeutics, Galderma SA, and Merz Pharma. These players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.
Key Market Segments
By Type
Hyaluronic acid (HA)
Age group
13 to 39
40 to 54
55 to 69
Calcium Hydroxylapatite (CaHA)
Poly L lactic Acid
Others
By Gender
Male
Female
By Service Provider
Specialty and Dermatology Clinics
Hospitals
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Teoxane Laboratories
Cutera Inc
Elan aesthetics Inc
Bioxis pharmaceutical
AbbVie Laboratories
Sinclair Pharma
Sosum Global
Revance Therapeutics
Galderma SA
Merz Pharma
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: DERMAL FILLER MARKET, BY TYPE
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Type
- 4.2. Hyaluronic Acid (HA)
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.2.5. Age group
- 4.2.5.1. Market Size and Forecast
- 4.2.5.2. 13 to 39
- 4.2.5.2.1. Market Size and Forecast
- 4.2.5.2. 40 to 54
- 4.2.5.2.1. Market Size and Forecast
- 4.2.5.2. 55 to 69
- 4.2.5.2.1. Market Size and Forecast
- 4.3. Calcium Hydroxylapatite (CaHA)
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- 4.4. Poly L Lactic Acid
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
- 4.5. Others
- 4.5.1. Key Market Trends, Growth Factors and Opportunities
- 4.5.2. Market Size and Forecast, By Region
- 4.5.3. Market Share Analysis, By Country
- CHAPTER 5: DERMAL FILLER MARKET, BY GENDER
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Gender
- 5.2. Male
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Female
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- CHAPTER 6: DERMAL FILLER MARKET, BY SERVICE PROVIDER
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Service Provider
- 6.2. Specialty And Dermatology Clinics
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Hospitals
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. Others
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
- CHAPTER 7: DERMAL FILLER MARKET, BY REGION
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
- 7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Type
- 7.2.3. Market Size and Forecast, By Gender
- 7.2.4. Market Size and Forecast, By Service Provider
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Dermal Filler Market
- 7.2.6.1. Market Size and Forecast, By Type
- 7.2.6.2. Market Size and Forecast, By Gender
- 7.2.6.3. Market Size and Forecast, By Service Provider
- 7.2.7. Canada Dermal Filler Market
- 7.2.7.1. Market Size and Forecast, By Type
- 7.2.7.2. Market Size and Forecast, By Gender
- 7.2.7.3. Market Size and Forecast, By Service Provider
- 7.2.8. Mexico Dermal Filler Market
- 7.2.8.1. Market Size and Forecast, By Type
- 7.2.8.2. Market Size and Forecast, By Gender
- 7.2.8.3. Market Size and Forecast, By Service Provider
- 7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Type
- 7.3.3. Market Size and Forecast, By Gender
- 7.3.4. Market Size and Forecast, By Service Provider
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. Germany Dermal Filler Market
- 7.3.6.1. Market Size and Forecast, By Type
- 7.3.6.2. Market Size and Forecast, By Gender
- 7.3.6.3. Market Size and Forecast, By Service Provider
- 7.3.7. France Dermal Filler Market
- 7.3.7.1. Market Size and Forecast, By Type
- 7.3.7.2. Market Size and Forecast, By Gender
- 7.3.7.3. Market Size and Forecast, By Service Provider
- 7.3.8. UK Dermal Filler Market
- 7.3.8.1. Market Size and Forecast, By Type
- 7.3.8.2. Market Size and Forecast, By Gender
- 7.3.8.3. Market Size and Forecast, By Service Provider
- 7.3.9. Italy Dermal Filler Market
- 7.3.9.1. Market Size and Forecast, By Type
- 7.3.9.2. Market Size and Forecast, By Gender
- 7.3.9.3. Market Size and Forecast, By Service Provider
- 7.3.10. Spain Dermal Filler Market
- 7.3.10.1. Market Size and Forecast, By Type
- 7.3.10.2. Market Size and Forecast, By Gender
- 7.3.10.3. Market Size and Forecast, By Service Provider
- 7.3.11. Rest Of Europe Dermal Filler Market
- 7.3.11.1. Market Size and Forecast, By Type
- 7.3.11.2. Market Size and Forecast, By Gender
- 7.3.11.3. Market Size and Forecast, By Service Provider
- 7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Type
- 7.4.3. Market Size and Forecast, By Gender
- 7.4.4. Market Size and Forecast, By Service Provider
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. Japan Dermal Filler Market
- 7.4.6.1. Market Size and Forecast, By Type
- 7.4.6.2. Market Size and Forecast, By Gender
- 7.4.6.3. Market Size and Forecast, By Service Provider
- 7.4.7. China Dermal Filler Market
- 7.4.7.1. Market Size and Forecast, By Type
- 7.4.7.2. Market Size and Forecast, By Gender
- 7.4.7.3. Market Size and Forecast, By Service Provider
- 7.4.8. India Dermal Filler Market
- 7.4.8.1. Market Size and Forecast, By Type
- 7.4.8.2. Market Size and Forecast, By Gender
- 7.4.8.3. Market Size and Forecast, By Service Provider
- 7.4.9. Australia Dermal Filler Market
- 7.4.9.1. Market Size and Forecast, By Type
- 7.4.9.2. Market Size and Forecast, By Gender
- 7.4.9.3. Market Size and Forecast, By Service Provider
- 7.4.10. South Korea Dermal Filler Market
- 7.4.10.1. Market Size and Forecast, By Type
- 7.4.10.2. Market Size and Forecast, By Gender
- 7.4.10.3. Market Size and Forecast, By Service Provider
- 7.4.11. Rest of Asia-Pacific Dermal Filler Market
- 7.4.11.1. Market Size and Forecast, By Type
- 7.4.11.2. Market Size and Forecast, By Gender
- 7.4.11.3. Market Size and Forecast, By Service Provider
- 7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Type
- 7.5.3. Market Size and Forecast, By Gender
- 7.5.4. Market Size and Forecast, By Service Provider
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Dermal Filler Market
- 7.5.6.1. Market Size and Forecast, By Type
- 7.5.6.2. Market Size and Forecast, By Gender
- 7.5.6.3. Market Size and Forecast, By Service Provider
- 7.5.7. Saudi Arabia Dermal Filler Market
- 7.5.7.1. Market Size and Forecast, By Type
- 7.5.7.2. Market Size and Forecast, By Gender
- 7.5.7.3. Market Size and Forecast, By Service Provider
- 7.5.8. South Africa Dermal Filler Market
- 7.5.8.1. Market Size and Forecast, By Type
- 7.5.8.2. Market Size and Forecast, By Gender
- 7.5.8.3. Market Size and Forecast, By Service Provider
- 7.5.9. Rest of LAMEA Dermal Filler Market
- 7.5.9.1. Market Size and Forecast, By Type
- 7.5.9.2. Market Size and Forecast, By Gender
- 7.5.9.3. Market Size and Forecast, By Service Provider
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top Winning Strategies
- 8.3. Product Mapping Of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top Player Positioning, 2023
- CHAPTER 9: COMPANY PROFILES
- 9.1. Teoxane Laboratories
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
- 9.2. Cutera Inc
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
- 9.3. Elan Aesthetics Inc
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
- 9.4. Bioxis Pharmaceutical
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
- 9.5. AbbVie Laboratories
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
- 9.6. Sinclair Pharma
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
- 9.7. Sosum Global
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
- 9.8. Revance Therapeutics
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
- 9.9. Galderma SA
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
- 9.10. Merz Pharma
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments
- TABLE 1. GLOBAL DERMAL FILLER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 2. DERMAL FILLER MARKET FOR HYALURONIC ACID (HA), BY REGION, 2024 - 2033 ($BILLION)
- TABLE 3. DERMAL FILLER MARKET FOR CALCIUM HYDROXYLAPATITE (CAHA), BY REGION, 2024 - 2033 ($BILLION)
- TABLE 4. DERMAL FILLER MARKET FOR POLY L LACTIC ACID, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 5. DERMAL FILLER MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 6. GLOBAL DERMAL FILLER MARKET, BY GENDER, 2024 - 2033 ($BILLION)
- TABLE 7. DERMAL FILLER MARKET FOR MALE, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 8. DERMAL FILLER MARKET FOR FEMALE, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 9. GLOBAL DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2024 - 2033 ($BILLION)
- TABLE 10. DERMAL FILLER MARKET FOR SPECIALTY AND DERMATOLOGY CLINICS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 11. DERMAL FILLER MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 12. DERMAL FILLER MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 13. DERMAL FILLER MARKET, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 14. NORTH AMERICA DERMAL FILLER MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 15. NORTH AMERICA DERMAL FILLER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 16. NORTH AMERICA DERMAL FILLER MARKET, BY GENDER, 2024 - 2033 ($BILLION)
- TABLE 17. NORTH AMERICA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2024 - 2033 ($BILLION)
- TABLE 18. U.S. DERMAL FILLER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 19. U.S. DERMAL FILLER MARKET, BY GENDER, 2024 - 2033 ($BILLION)
- TABLE 20. U.S. DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2024 - 2033 ($BILLION)
- TABLE 21. CANADA DERMAL FILLER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 22. CANADA DERMAL FILLER MARKET, BY GENDER, 2024 - 2033 ($BILLION)
- TABLE 23. CANADA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2024 - 2033 ($BILLION)
- TABLE 24. MEXICO DERMAL FILLER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 25. MEXICO DERMAL FILLER MARKET, BY GENDER, 2024 - 2033 ($BILLION)
- TABLE 26. MEXICO DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2024 - 2033 ($BILLION)
- TABLE 27. EUROPE DERMAL FILLER MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 28. EUROPE DERMAL FILLER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 29. EUROPE DERMAL FILLER MARKET, BY GENDER, 2024 - 2033 ($BILLION)
- TABLE 30. EUROPE DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2024 - 2033 ($BILLION)
- TABLE 31. GERMANY DERMAL FILLER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 32. GERMANY DERMAL FILLER MARKET, BY GENDER, 2024 - 2033 ($BILLION)
- TABLE 33. GERMANY DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2024 - 2033 ($BILLION)
- TABLE 34. FRANCE DERMAL FILLER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 35. FRANCE DERMAL FILLER MARKET, BY GENDER, 2024 - 2033 ($BILLION)
- TABLE 36. FRANCE DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2024 - 2033 ($BILLION)
- TABLE 37. UK DERMAL FILLER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 38. UK DERMAL FILLER MARKET, BY GENDER, 2024 - 2033 ($BILLION)
- TABLE 39. UK DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2024 - 2033 ($BILLION)
- TABLE 40. ITALY DERMAL FILLER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 41. ITALY DERMAL FILLER MARKET, BY GENDER, 2024 - 2033 ($BILLION)
- TABLE 42. ITALY DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2024 - 2033 ($BILLION)
- TABLE 43. SPAIN DERMAL FILLER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 44. SPAIN DERMAL FILLER MARKET, BY GENDER, 2024 - 2033 ($BILLION)
- TABLE 45. SPAIN DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2024 - 2033 ($BILLION)
- TABLE 46. REST OF EUROPE DERMAL FILLER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 47. REST OF EUROPE DERMAL FILLER MARKET, BY GENDER, 2024 - 2033 ($BILLION)
- TABLE 48. REST OF EUROPE DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2024 - 2033 ($BILLION)
- TABLE 49. ASIA-PACIFIC DERMAL FILLER MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 50. ASIA-PACIFIC DERMAL FILLER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 51. ASIA-PACIFIC DERMAL FILLER MARKET, BY GENDER, 2024 - 2033 ($BILLION)
- TABLE 52. ASIA-PACIFIC DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2024 - 2033 ($BILLION)
- TABLE 53. JAPAN DERMAL FILLER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 54. JAPAN DERMAL FILLER MARKET, BY GENDER, 2024 - 2033 ($BILLION)
- TABLE 55. JAPAN DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2024 - 2033 ($BILLION)
- TABLE 56. CHINA DERMAL FILLER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 57. CHINA DERMAL FILLER MARKET, BY GENDER, 2024 - 2033 ($BILLION)
- TABLE 58. CHINA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2024 - 2033 ($BILLION)
- TABLE 59. INDIA DERMAL FILLER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 60. INDIA DERMAL FILLER MARKET, BY GENDER, 2024 - 2033 ($BILLION)
- TABLE 61. INDIA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2024 - 2033 ($BILLION)
- TABLE 62. AUSTRALIA DERMAL FILLER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 63. AUSTRALIA DERMAL FILLER MARKET, BY GENDER, 2024 - 2033 ($BILLION)
- TABLE 64. AUSTRALIA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2024 - 2033 ($BILLION)
- TABLE 65. SOUTH KOREA DERMAL FILLER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 66. SOUTH KOREA DERMAL FILLER MARKET, BY GENDER, 2024 - 2033 ($BILLION)
- TABLE 67. SOUTH KOREA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2024 - 2033 ($BILLION)
- TABLE 68. REST OF ASIA-PACIFIC DERMAL FILLER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 69. REST OF ASIA-PACIFIC DERMAL FILLER MARKET, BY GENDER, 2024 - 2033 ($BILLION)
- TABLE 70. REST OF ASIA-PACIFIC DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2024 - 2033 ($BILLION)
- TABLE 71. LAMEA DERMAL FILLER MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 72. LAMEA DERMAL FILLER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 73. LAMEA DERMAL FILLER MARKET, BY GENDER, 2024 - 2033 ($BILLION)
- TABLE 74. LAMEA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2024 - 2033 ($BILLION)
- TABLE 75. BRAZIL DERMAL FILLER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 76. BRAZIL DERMAL FILLER MARKET, BY GENDER, 2024 - 2033 ($BILLION)
- TABLE 77. BRAZIL DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2024 - 2033 ($BILLION)
- TABLE 78. SAUDI ARABIA DERMAL FILLER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 79. SAUDI ARABIA DERMAL FILLER MARKET, BY GENDER, 2024 - 2033 ($BILLION)
- TABLE 80. SAUDI ARABIA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2024 - 2033 ($BILLION)
- TABLE 81. SOUTH AFRICA DERMAL FILLER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 82. SOUTH AFRICA DERMAL FILLER MARKET, BY GENDER, 2024 - 2033 ($BILLION)
- TABLE 83. SOUTH AFRICA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2024 - 2033 ($BILLION)
- TABLE 84. REST OF LAMEA DERMAL FILLER MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 85. REST OF LAMEA DERMAL FILLER MARKET, BY GENDER, 2024 - 2033 ($BILLION)
- TABLE 86. REST OF LAMEA DERMAL FILLER MARKET, BY SERVICE PROVIDER, 2024 - 2033 ($BILLION)
- TABLE 87. TEOXANE LABORATORIES: KEY EXECUTIVES
- TABLE 88. TEOXANE LABORATORIES: COMPANY SNAPSHOT
- TABLE 89. TEOXANE LABORATORIES: OPERATING SEGMENTS
- TABLE 90. TEOXANE LABORATORIES: PRODUCT PORTFOLIO
- TABLE 91. TEOXANE LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 92. CUTERA INC: KEY EXECUTIVES
- TABLE 93. CUTERA INC: COMPANY SNAPSHOT
- TABLE 94. CUTERA INC: OPERATING SEGMENTS
- TABLE 95. CUTERA INC: PRODUCT PORTFOLIO
- TABLE 96. CUTERA INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 97. ELAN AESTHETICS INC: KEY EXECUTIVES
- TABLE 98. ELAN AESTHETICS INC: COMPANY SNAPSHOT
- TABLE 99. ELAN AESTHETICS INC: OPERATING SEGMENTS
- TABLE 100. ELAN AESTHETICS INC: PRODUCT PORTFOLIO
- TABLE 101. ELAN AESTHETICS INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 102. BIOXIS PHARMACEUTICAL: KEY EXECUTIVES
- TABLE 103. BIOXIS PHARMACEUTICAL: COMPANY SNAPSHOT
- TABLE 104. BIOXIS PHARMACEUTICAL: OPERATING SEGMENTS
- TABLE 105. BIOXIS PHARMACEUTICAL: PRODUCT PORTFOLIO
- TABLE 106. BIOXIS PHARMACEUTICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 107. ABBVIE LABORATORIES: KEY EXECUTIVES
- TABLE 108. ABBVIE LABORATORIES: COMPANY SNAPSHOT
- TABLE 109. ABBVIE LABORATORIES: OPERATING SEGMENTS
- TABLE 110. ABBVIE LABORATORIES: PRODUCT PORTFOLIO
- TABLE 111. ABBVIE LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 112. SINCLAIR PHARMA: KEY EXECUTIVES
- TABLE 113. SINCLAIR PHARMA: COMPANY SNAPSHOT
- TABLE 114. SINCLAIR PHARMA: OPERATING SEGMENTS
- TABLE 115. SINCLAIR PHARMA: PRODUCT PORTFOLIO
- TABLE 116. SINCLAIR PHARMA: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 117. SOSUM GLOBAL: KEY EXECUTIVES
- TABLE 118. SOSUM GLOBAL: COMPANY SNAPSHOT
- TABLE 119. SOSUM GLOBAL: OPERATING SEGMENTS
- TABLE 120. SOSUM GLOBAL: PRODUCT PORTFOLIO
- TABLE 121. SOSUM GLOBAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 122. REVANCE THERAPEUTICS: KEY EXECUTIVES
- TABLE 123. REVANCE THERAPEUTICS: COMPANY SNAPSHOT
- TABLE 124. REVANCE THERAPEUTICS: OPERATING SEGMENTS
- TABLE 125. REVANCE THERAPEUTICS: PRODUCT PORTFOLIO
- TABLE 126. REVANCE THERAPEUTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 127. GALDERMA SA: KEY EXECUTIVES
- TABLE 128. GALDERMA SA: COMPANY SNAPSHOT
- TABLE 129. GALDERMA SA: OPERATING SEGMENTS
- TABLE 130. GALDERMA SA: PRODUCT PORTFOLIO
- TABLE 131. GALDERMA SA: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 132. MERZ PHARMA: KEY EXECUTIVES
- TABLE 133. MERZ PHARMA: COMPANY SNAPSHOT
- TABLE 134. MERZ PHARMA: OPERATING SEGMENTS
- TABLE 135. MERZ PHARMA: PRODUCT PORTFOLIO
- TABLE 136. MERZ PHARMA: KEY STRATEGIC MOVES AND DEVELOPMENTS
- FIGURE 1. GLOBAL DERMAL FILLER MARKET, 2024 - 2033
- FIGURE 2. SEGMENTATION OF DERMAL FILLER MARKET, 2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN DERMAL FILLER MARKET
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALDERMAL FILLER MARKET
- FIGURE 10. GLOBAL DERMAL FILLER MARKET SEGMENTATION, BY TYPE
- FIGURE 11. DERMAL FILLER MARKET FOR HYALURONIC ACID (HA), BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 12. DERMAL FILLER MARKET FOR CALCIUM HYDROXYLAPATITE (CAHA), BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 13. DERMAL FILLER MARKET FOR POLY L LACTIC ACID, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 14. DERMAL FILLER MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 15. GLOBAL DERMAL FILLER MARKET SEGMENTATION, BY GENDER
- FIGURE 16. DERMAL FILLER MARKET FOR MALE, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 17. DERMAL FILLER MARKET FOR FEMALE, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 18. GLOBAL DERMAL FILLER MARKET SEGMENTATION, BY SERVICE PROVIDER
- FIGURE 19. DERMAL FILLER MARKET FOR SPECIALTY AND DERMATOLOGY CLINICS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 20. DERMAL FILLER MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 21. DERMAL FILLER MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 22. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 23. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 24. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 25. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 26. COMPETITIVE DASHBOARD
- FIGURE 27. COMPETITIVE HEATMAP: DERMAL FILLER MARKET
- FIGURE 28. TOP PLAYER POSITIONING, 2023
- FIGURE 29. TEOXANE LABORATORIES: NET SALES, 2021-2023 ($BILLION)
- FIGURE 30. TEOXANE LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 31. TEOXANE LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 32. CUTERA INC: NET SALES, 2021-2023 ($BILLION)
- FIGURE 33. CUTERA INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 34. CUTERA INC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 35. ELAN AESTHETICS INC: NET SALES, 2021-2023 ($BILLION)
- FIGURE 36. ELAN AESTHETICS INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 37. ELAN AESTHETICS INC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 38. BIOXIS PHARMACEUTICAL: NET SALES, 2021-2023 ($BILLION)
- FIGURE 39. BIOXIS PHARMACEUTICAL: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 40. BIOXIS PHARMACEUTICAL: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 41. ABBVIE LABORATORIES: NET SALES, 2021-2023 ($BILLION)
- FIGURE 42. ABBVIE LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 43. ABBVIE LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 44. SINCLAIR PHARMA: NET SALES, 2021-2023 ($BILLION)
- FIGURE 45. SINCLAIR PHARMA: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 46. SINCLAIR PHARMA: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 47. SOSUM GLOBAL: NET SALES, 2021-2023 ($BILLION)
- FIGURE 48. SOSUM GLOBAL: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 49. SOSUM GLOBAL: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 50. REVANCE THERAPEUTICS: NET SALES, 2021-2023 ($BILLION)
- FIGURE 51. REVANCE THERAPEUTICS: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 52. REVANCE THERAPEUTICS: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 53. GALDERMA SA: NET SALES, 2021-2023 ($BILLION)
- FIGURE 54. GALDERMA SA: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 55. GALDERMA SA: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 56. MERZ PHARMA: NET SALES, 2021-2023 ($BILLION)
- FIGURE 57. MERZ PHARMA: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 58. MERZ PHARMA: REVENUE SHARE, BY REGION, 2023 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook